Document:

Filed by sedaredgar.com - Bark Group Inc. - Exhibit 10.29

EXHIBIT 10.29

BARK GROUP INC. 
Ostergrade 17-19, 3rd Floor,
DK-1100 Copenhagen K, Denmark 

April 7, 2009 

Debondo Capital Limited 
DeBondo Capital Limited
(Hongkong) 
Suite 813, Hollywood Plaza, 
610 Nathan Road, 
Kowloon,
Hong Kong 

Dear Sirs/Mesdames: 

We write further to the following agreements: 

	Indemnification Agreement between Bark Corporation A/S (“Bark”) and
  DeBondo Capital Limited (Hongkong) ("DeBondo HK") dated February 29,
  2008 (the "Indemnification Agreement"); 

  
	Consulting agreement Bark and DeBondo Capital Limited ("DeBondo")
  dated October 2, 2007 (the "Consulting Agreement"); and 

  
	Letter Agreement dated June 30, 2008 pursuant to which each of the
  Indemnification Agreement and the Consulting Agreement were amended (the
  “First Amendment Agreement”). 

Further to our discussions, we write to confirm our agreement
to amend the Indemnification Agreement and the Consulting Agreement on the
following basis: 

	The Indemnification Agreement, as amended by the First Amendment
  Agreement, is hereby amended to provide that the date of termination of the
  obligation of DeBondo HK to pay to Bark Group a compensation of $25,000, as
  set forth in Section 2.2 of the Indemnification Agreement, is extended from
  October 30, 2008 to July 31, 2009 in order to reflect the extension of the
  date for exercise of the right of repurchase under the repurchase and lock-up
  agreements entered into between Bark Group and the original shareholders of
  Bark Group (the “Repurchase Agreements”) from September 30, 2008 to
  June 30, 2009. For clarification, the June 30, 2008 date referred to in
  Section 3.1(b) of the original Indemnification Agreement is hereby replaced
  with July 10th, 2009 and the Indemnification Agreement shall
  continue without termination until such date. 

  
	The Consultant Agreement, as amended by the First Amendment Agreement, is
  hereby amended to provide that payment of the US$225,000 cash fee originally
  payable on final receipt and acceptance of Bark’s Form 211 with NASD (issue of
  ticker symbol) will only 

Page 2 

  be due and payable upon completion by Bark Group of the $2,5
    million equity financing contemplated pursuant to either: 

  	the agreement between Bark and PacificWave Partners Limited, or 

      

    
	by any other party, provided that in this case the financing completes by
      June 30, 2009. 

      

    
	Each of the Indemnification Agreement and the Consulting Agreement will
      continue in full, force and effect without amendment except as expressly
      provided herein. 

If these amendments to the Indemnification Agreement and the
Consulting Agreement are acceptable to DeBondo and DeBondo HK, we ask that you
execute a copy of this letter where indicated below and return it to us
forthwith. 

Yours truly, 

	BARK CORPORATION AS 
	  	  
	Per: 	/s/ Bent Helvang 
	  	Bent Helvang, Chairman

	BARK GROUP INC. 
	  	  
	Per: 	/s/ Bent Helvang 
	  	Bent Helvang, Chairman

	Accepted and Agreed effective
      the 8th day of April, 2009. 	 
	  	  	 
	DEBONDO CAPITAL LIMITED 	 
	  	  	 
	  	  	 
	Per: 	/s/ Ulrik Debo
      	 
	  	ULRIK DEBO 	 
	  	Authorized Signatory
    	 
	  	  	 
	DEBONDO CAPITAL LIMITED (HONGKONG) 	 
	  	  	 
	  	  	 
	Per: 	/s/ Ulrik Debo
      	 
	  	ULRIK DEBO 	 
	  	Authorized SignatoryFiled by sedaredgar.com - Bark Group Inc. - Exhibit 10.30

EXHIBIT 10.30 

BARK GROUP INC. 
Ostergade 17-19,
3rd Floor, DK-1100 Copenhagen K, Denmark

March 19, 2009 

PACIFICWAVE PARTNERS LIMITED

50 California Street, Suite 1500

  San Francisco, CA 94111

Dear Sirs/Mesdames: 

	Re: 	Engagement Agreement originally
      “Engagement Agreement”) dated August 17,
      2007, as amended (the 

We write to confirm our agreement to extend the previous
September 30th, 2008 termination date to June 30, 2009 by amending
Paragraph 2 of the Engagement Agreement entitled “Term of Engagement” to read as
follows: 

  
    
      “The term of this Agreement shall be for a period of 36 months
        (the “Term”) commencing from the date that PacificWave receives a copy of this
        Agreement executed by the Company. PacificWave shall be the exclusive financial
        advisors to the Company during the Term. Thereafter, this Agreement shall renew
        automatically for successive terms of 12 months (each, a “Renewal Term”) unless
        either party shall give twenty (20) days’ written notice of termination to the
        other party before the commencement of any Renewal Term. Any termination of this
        Agreement pursuant to this paragraph 2 shall be without liability of any
        character (including, but not limited to, loss of anticipated profits or
        consequential damages) on the part of any party thereto, except that the Company
        shall remain obligated to pay all fees and expenses provided to be paid by it
        specified in paragraphs 3, 4, 5 and 6 of this Agreement. The Agreement can be
          terminated with 6 month notice by the company during the full term of
          engagement. If the financial targets mentioned in first paragraph (top of page
          1) in this Agreement have not been achieved by PacificWave before June
          30th, 2009, the contract is to be considered null and
            void from that date. In such event the company will only pay approved invoices
            to date..” 

    

  

The Engagement Agreement will continue in full force and effect
without amendment except as provided for herein. 

If these amendments to the Engagement Agreement are acceptable
to you, we ask that you execute a copy of this letter where indicated below and
return it to us as early as possible. Yours truly, 

	BARK GROUP INC. 
	 
	Per: 	/s/ Bent Helvang 
	 	 
	  	Bent Helvang, Chairman
  

Accepted and agreed as of this 19th. day of March,
2009. 

	PACIFICWAVE PARTNERS LIMITED 
	 
	Per: 	/s/ Henrik Rouf 
	 	 
	  	Henrik Rouf, Managing
      Director 
	  	Authorized Signatoryzynex10k123108x1033_41509.htm

    Exhibit 10.33

    

    [[Company Logo]]  Marquette Healthcare
Finance 

     

    By
Email and US Mail

     

     

    April 7,
2009

     

    

    

    
      	
              Mr.
      Thomas Sandgaard, CEO

              Mr.
      Fritz Allison, CFO

              8022
      Southpark Circle

              Littleton,
      CO 80120

            

    

    
      	
               
      

            	 

    

     

    
      	
               
      

            	
              Re:

            	
              Loan
      and Security Agreement 

            

    

     

    Dear Mr. Sandgaard and Mr. Allison:

     

    Marquette Healthcare Finance
(“Marquette”) is providing written notice to Zynex, Inc., and Zynex Medical,
Inc. (“Zynex”) of default under the Loan and Security Agreement entered into
between Zynex and Marquette on September 23, 2008.

    

    Zynex is
in default as follows:

    

    Financial
Covenants

    

    The
financial covenants contained in the Loan and Security Agreement are important
because they show the financial condition of Zynex.  Under Section 9.1
of the amended Loan and Security Agreement, Zynex is to maintain the following
financial covenants:

    

    
      	
              1.  

            	
              TTM
      EBITDA:  $6,500,000 at the end of fourth quarter,
      2008.

            

    

    
      	
              2.  

            	
              Debt
      Service Coverage Ratio: 3.00 at the end of fourth quarter,
      2008.

            

    

    
      	
              3.  

            	
              TTM
      EBITDA:  $7,500,000 at the end of first quarter, March 31,
      2009

            

    

    

    The
Covenant Certificate provided by Zynex to Marquette for the quarter ending
December 31, 2008 shows that Zynex has failed to meet the minimum financial
covenant for the TTM EBITDA as follows:

     

     

    

    
      
        
          
            900 SW
Fifth Avenue, Suite 1920

            Portland,
OR 97204

            www.marquettehf.com

            503.525.5402

          

           

        

        
           

          
            

          

        

        
           

        

      

    

    

    

    
      	
              1.  

            	
              TTM
      EBITDA:   $826,661

            

    

    

    

    The
Covenant Certificate provided by Zynex to Marquette for the quarter ending
December 31, 2008 shows that Zynex has failed to meet the minimum financial
covenant for the minimum Debt Service Coverage Ratio as follows:

    

    
      	
              2.  

            	
              Q4
      2008 DSC: 1.59:1.00

            

    

    

    The
financial projections provided by Zynex to Marquette for the quarter ending
March 31, 2009 show that Zynex will fail to meet the minimum financial covenant
for the TTM EBITDA as follows:

    

    
      	
              3.  

            	
              TTM
      EBITDA:   $1,239,000

            

    

    

    Opportunity
to Cure and Proposal

    

    
      	
              1.  

            	
              The
      default concerning Zynex’s failure to meet the TTM EBITDA covenant at the
      quarter ending December 31, 2008 and the anticipated default regarding the
      failure to meet the TTM EBITDA covenant at the quarter ending March 31,
      2009 are not curable based on financial statements and projections for
      these dates.  Marquette
      is willing to forbear taking action on the financial covenant defaults for
      the quarters ending December 31, 2008 and March 31, 2009; specifically,
      waiving a default fee and default interest
rate.

            

    

    

    Marquette
will re-set the TTM EBITDA covenant for the remainder of the year as
follows:

    
      

      
        
          	
                  000’s

                	
                  9/31/2008

                	
                  12/31/2008

                	
                  3/31/2009

                	
                  6/30/2009

                	
                  9/30/2009

                	
                  12/31/2009

                
	
                  Orig.
      TTM EBITDA Covenent

                	
                  Waived

                	
                  6,500

                	
                  7,500

                	
                  8,200

                	
                  11,500

                	
                  13,000

                
	
                  TIM
      EBITDA Actual

                	
                  7,430

                	
                  827

                	 
      	 
      	 
      	 
      
	
                  TIM
      EBITDA Projected

                	 
      	 
      	
                  1,239

                	
                  1,795

                	
                  4,065

                	
                  5,139

                
	
                  MHF
      Proposed EBITDA Reset

                	 
      	
                  Waive

                	
                  Waive

                	
                  1,436

                	
                  3,252

                	
                  4,111

                
	 
      	 
      	 
      	 
      	 
      	 
      	 
      

      

    

    When
available, financial projections for 2010 will be used to set future TTM EBITDA
covenant targets in Marquette’s sole discretion.

    

    
      	
              2.  

            	
              The
      default concerning Zynex’s failure to meet the Debt Service Coverage ratio
      covenant at the quarter ending December 31, 2008 is not curable based on
      financial statements for the same date.  Marquette
      is willing to forbear taking action on the financial covenant default for
      the quarter ending December 31, 2008; specifically, waiving a default fee
      and default interest rate.

               

               

            

    

     

     

    

    
      
        
          
            900 SW
Fifth Avenue, Suite 1920

            Portland,
OR 97204

            www.marquettehf.com

            503.525.5402

          

           

        

        
           

          
            

          

        

        
           

        

      

    

    

    

    
      	
              3.  

            	
              Zynex
      has restated its unaudited financial statements for the quarters ended
      March 31, June 30 and September 30, 2008.  Marquette waives any
      breach of a representation, warranty or covenant concerning the accuracy
      of the original unaudited financial statements for these quarterly
      periods.  Notwithstanding the foregoing, Marquette expressly
      reserves any right to declare a default, and any other claim, right or
      remedy with respect to (a) the restated financial statements for these
      quarterly periods; and (b) any fraud or intentional misrepresentation in
      connection with the original financial statements for these quarterly
      periods.

            

    

    

    
      	
              4.  

            	
              Marquette
      will amend the Loan and Security Agreement to reflect the following
      pricing change:

            

    

    

    
      	
              ·  

            	
              Margin:  3.25%

            

    

    
      	
              ·  

            	
              Collateral
      Monitoring fee:  $1,750 per month, payable in arrears on the
      first day of the month.

            

    

    

    

    Marquette
expressly reserves the right to take action for financial covenant defaults in
subsequent reporting periods or upon any other default under the Loan
Documents.

    

    If the
above proposal is agreeable, please sign a copy of this letter and return it to
me.

    

    Regards,

    

    

    

    /s/
Jonathan W. Kott

    Jonathan
W. Kott

    Senior
Relationship Manage

    

    Marquette’s
proposal detailed above is accepted:

     

            /s/ Thomas
Sandgaard

            Thomas
Sandgaard

            Zynex, Inc.
and Zynex Medical, Inc.

    

    cc:    Marty
Golden

       Jennifer
Sheasgreen

     

     

    

    

    
      
        
          
            900 SW
Fifth Avenue, Suite 1920

            Portland,
OR 97204

            www.marquettehf.com

            503.525.5402

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]